Cleveland Clinic Lerner Research Institute

Cleveland Clinic Lerner Research Institute
Name	Cleveland Clinic Lerner Research Institute
Established	1998
Director	Serpil Erzurum, M.D.
Parent	Cleveland Clinic
Location	Cleveland, Ohio, United States

Cleveland Clinic Lerner Research Institute is one of the nation's leading biomedical research centers, dedicated to advancing scientific discovery and translating findings into improved patient care. As an integral component of the Cleveland Clinic health system, it fosters a highly collaborative environment where scientists and physicians work side-by-side. The institute's mission encompasses fundamental, translational, and clinical research aimed at understanding disease mechanisms and developing novel therapies. Its work spans numerous disciplines, contributing significantly to the global biomedical research landscape.

History and Founding

The institute was formally established in 1998, named in honor of philanthropists Al Lerner and his family, whose transformative gift enabled its creation and expansion. This development marked a strategic commitment by the Cleveland Clinic to deepen its investment in foundational scientific inquiry alongside its renowned clinical practice. The founding vision was to create a world-class research enterprise physically integrated within the main campus in Cleveland, promoting seamless interaction between laboratory scientists and practicing clinicians. Since its inception, it has grown exponentially in size, scope, and national reputation, evolving from a collection of laboratories into a unified, premier research institution.

Research Programs and Departments

Research is organized into multidisciplinary departments and centers that focus on cutting-edge areas of biomedicine. Core departments include Cancer Biology, Cardiovascular & Metabolic Sciences, Inflammation & Immunity, and Stem Cell Biology & Regenerative Medicine. The institute also houses specialized centers such as the Center for Clinical Genomics, the Center for Microbiome and Human Health, and the Brain Tumor Institute. These programs leverage advanced technologies in genomics, proteomics, and biomedical engineering to investigate a wide spectrum of conditions, from Alzheimer's disease and multiple sclerosis to cardiovascular disease and cancer.

Key Discoveries and Scientific Contributions

Researchers have been responsible for numerous landmark contributions that have reshaped medical understanding and practice. Pioneering work includes the discovery of the first mutations in the PTEN gene linked to Cowden syndrome and certain cancers, and the identification of chemerin as a key adipokine involved in obesity and diabetes. The institute has made significant advances in tissue engineering, including the first successful larynx transplant and pioneering research in bioartificial organs. Its scientists have also played crucial roles in elucidating pathways in vascular biology and atherosclerosis, and in developing novel immunotherapies for brain tumors.

Facilities and Resources

The institute occupies state-of-the-art facilities on the main campus of the Cleveland Clinic, including the Lerner Research Institute building and the recently constructed Sheila and Eric Samson Pavilion. These spaces house advanced core laboratories for genomic sequencing, flow cytometry, bioinformatics, microscopy, and animal research. Resources include the Cleveland Clinic Biorepository, which provides annotated human tissue samples for research, and high-performance computing clusters for data-intensive science. The integrated design encourages collaboration across departments and with clinicians from the adjacent Cleveland Clinic Main Campus hospitals.

Leadership and Notable Researchers

The institute is led by Scientific Director Serpil Erzurum, an internationally recognized physician-scientist in pulmonary and critical care medicine. Historically, it was directed by eminent figures like Paul DiCorleto. The faculty includes many notable investigators such as Charis Eng, a pioneer in cancer genetics; Stanley Hazen, known for his work on gut microbiome metabolites and heart disease; and Jerold Chun, who discovered somatic gene recombination in the brain. Many researchers hold joint appointments with affiliated institutions like Case Western Reserve University and have been recognized by honors including the Lasker Award and membership in the National Academy of Sciences.

Education and Training Programs

A major focus is training the next generation of biomedical scientists through robust academic programs. The institute serves as the research home for the Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, a unique five-year program that graduates physician-investigators. It also offers PhD and MD-PhD programs in partnership with Case Western Reserve University and other local universities. Extensive postdoctoral fellowship programs, summer internships for undergraduate students, and research rotations for medical residents and clinical fellows provide comprehensive training across the research continuum.

Collaborations and Affiliations

The institute maintains a vast network of scientific partnerships that amplify its research impact. It has strong academic ties with Case Western Reserve University, including the Case Comprehensive Cancer Center and the Clinical and Translational Science Collaborative. National and international consortia participation includes the Cancer Genome Atlas and the International Cancer Genome Consortium. Strategic alliances with industry partners in the pharmaceutical and biotechnology sectors facilitate the translation of discoveries into diagnostics and therapeutics. These collaborations extend its reach into global health initiatives and large-scale population studies.

Category:Medical and health organizations based in Ohio Category:Research institutes in the United States Category:Cleveland Clinic